A Case-Based Approach to CLL and Mantle Cell Lymphoma: Novel Therapies and Transplant Options

Using a case-based format and the latest research, experts will address the clinical management of patients with CLL and MCL and discuss both frontline and salvage therapies.  Such therapies will include conventional chemotherapy as well as transplant approaches.  For CLL, what is the risk-adapted sequence for treatment and who can benefit from earlier and more aggressive therapeutic interventions, including hematopoietic cell transplantation (HCT)?  For MCL, what are the optimal therapeutic approaches for this challenging disease using standard agents, novel approaches, and HCT?

Access the course 

ACCME Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Medical College of Wisconsin and National Marrow Donor Program. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
 
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this Enduring material for a maximum of 3.5 AMA PRA Category 1 Credit(s) ™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 
Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 3.5 hours of participation for continuing education for allied health professionals.

Target Audience

Hematologists/oncologists who treat MCL and CLL

Learning Objectives

At the conclusion of this activity, I will be able to

1. Identify biologic and clinical factors and current recommendations in selecting risk-adapted treatment for CLL.

2. Determine timing of transplant for CLL based on patient risk, disease and molecular factors.

3. Evaluate outcomes for current therapeutic approaches to MCL.

4. Compare the risks and benefits of MCL treatment approach, and how timing of  transplant and clinical patient characteristics affects outcomes.

Additional information

Contact

Name: 
Ellyce Hayes
Phone Number: 
+1 (612) 460-4231
Email: 
[email protected]
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.
Course opens: 
06/02/2014
Course expires: 
06/01/2015
Cost:
$0.00
Planning Committee:
 
Dennis Confer, MD
Willis Navarro, MD
Navneet Majhail, MD
Ginna LaPort, MD
Alissa Salvato, BA
Darlene Haven, BS
Ellyce Hayes, RD
Renee Ryan
 
Presenters:
Peter Dreger, MD
Ajay Gopal, MD
Thomas Kipps, MD
Willis Navarro, MD
Julie Vose, MD
 
All persons in control of content have NO relevant financial relationships to disclose with the exception of the following:

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Price

Cost:
$0.00
Please login or register to take this course.